{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:33Z","timestamp":1792783413142,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Viatris Pty Ltd"},{"name":"The University of Sydney","id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40265-026-02377-z","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:56:59Z","timestamp":1789185419000},"page":"1693-1703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials"],"prefix":"10.1007","volume":"86","author":[{"given":"Carlos","family":"Mesa-Castrillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Beckenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"2377_CR1","unstructured":"Therapeutic Goods Administration. Department of Health and Ageing. Australian Government. Australian Public Assessment Report (AusPAR) for Celecoxib. Celebrex Celecoxib Pfizer Australia Pty Ltd PM-2009-01564-3-1. 2010; https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-celebrex.pdf."},{"issue":"26","key":"2377_CR2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans DN, Solomon HD, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519\u201329.","journal-title":"N Engl J Med"},{"issue":"11","key":"2377_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/apt.14610","volume":"47","author":"ND Yeomans","year":"2018","unstructured":"Yeomans ND, Graham DY, Husni ME, et al. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther. 2018;47(11):1453\u201363.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10087","key":"2377_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/S0140-6736(17)30981-9","volume":"389","author":"FKL Chan","year":"2017","unstructured":"Chan FKL, Ching JYL, Tse YK, et al. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet. 2017;389(10087):2375\u201382.","journal-title":"Lancet"},{"issue":"10","key":"2377_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40265-025-02234-5","volume":"85","author":"C Beaudart","year":"2025","unstructured":"Beaudart C, Brabant C, Alokail M, Reginster J-Y, Bruy\u00e8re O. Current evidence on celecoxib safety in the management of chronic musculoskeletal conditions: an umbrella review. Drugs. 2025;85(10):1289\u2013306.","journal-title":"Drugs"},{"key":"2377_CR6","unstructured":"Therapeutic Goods Administration. Department of Health and Aged Care. Australian Government. Notice of final decisions to amend (or not amend) the current Poisons Standard. 2023; https:\/\/www.tga.gov.au\/sites\/default\/files\/2023-09\/notice-final-decision-amend-not-amend-current-poisons-standard-acms41-accs-36-joint-acms-accs-33.pdf."},{"key":"2377_CR7","unstructured":"Therapeutic Goods Administration. Department of Health and Aged Care. Australian Government. Notice of interim decisions to amend (or not amend) the current Poisons Standard. 2023; Available from: https:\/\/www.tga.gov.au\/sites\/default\/files\/2023-07\/public-notice-of-interim-decisions-acms-41-accs-36-joint-acms-accs-33-march-2023.pdf."},{"issue":"9894","key":"2377_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769\u201379.","journal-title":"Lancet"},{"key":"2377_CR9","doi-asserted-by":"crossref","unstructured":"Derry, S. and R.A. Moore, Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013(10).","DOI":"10.1002\/14651858.CD010107.pub2"},{"key":"2377_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"9","key":"2377_CR11","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.7326\/M22-1460","volume":"175","author":"LM DeTora","year":"2022","unstructured":"DeTora LM, Toroser D, Sykes A, et al. Good publication practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2022;175(9):1298\u2013304.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2377_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"key":"2377_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"2377_CR14","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime, 2023. Available from gradepro.org. 2023."},{"key":"2377_CR15","unstructured":"Sch\u00fcnemann H, B.J., Guyatt G, Oxman A, editors,. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. Available from guidelinedevelopment.org\/handbook. 2013."},{"key":"2377_CR16","unstructured":"Higgins JPT, T.J., Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s),. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. http:\/\/www.cochrane.org\/handbook. 2024."},{"key":"2377_CR17","unstructured":"The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 7.2.0. . 2024; https:\/\/revman.cochrane.org."},{"issue":"11","key":"2377_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"10","key":"2377_CR19","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/ejp.2021","volume":"26","author":"R Langford","year":"2022","unstructured":"Langford R, Morte A, Sust M, et al. Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: a randomized, double-blind, phase 3 trial (STARDOM2). Eur J Pain. 2022;26(10):2083\u201396.","journal-title":"Eur J Pain"},{"issue":"11","key":"2377_CR20","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1526-4637.2012.01479.x","volume":"13","author":"G Manvelian","year":"2012","unstructured":"Manvelian G, Daniels S, Gibofsky A. A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac. Pain Med. 2012;13(11):1491\u20138.","journal-title":"Pain Med"},{"issue":"8","key":"2377_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/papr.13399","volume":"24","author":"ER Viscusi","year":"2024","unstructured":"Viscusi ER, de Leon-Casasola O, Cebrecos J, et al. Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial. Pain Pract. 2024;24(8):1042\u201350.","journal-title":"Pain Pract"},{"issue":"Suppl","key":"2377_CR22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.clinthera.2007.12.008","volume":"29","author":"R Cheung","year":"2007","unstructured":"Cheung R, Krishnaswami S, Kowalski K. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. Clin Ther. 2007;29(Suppl):2498\u2013510.","journal-title":"Clin Ther"},{"key":"2377_CR23","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.2147\/NDT.S151834","volume":"13","author":"S Munjal","year":"2017","unstructured":"Munjal S, Bennett A. Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study. Neuropsychiatr Dis Treat. 2017;13:2797\u2013802.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2377_CR24","doi-asserted-by":"publisher","first-page":"7088004","DOI":"10.1155\/2023\/7088004","volume":"2023","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liu X, Ding C, Xiang B, Yan L. Positive preemptive analgesia effectiveness of pregabalin combined with celecoxib in total knee arthroplasty: a prospective controlled randomized study. Pain Res Manag. 2023;2023:7088004.","journal-title":"Pain Res Manag"},{"issue":"4","key":"2377_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00042737-200304000-00011","volume":"15","author":"M Ekenel","year":"2003","unstructured":"Ekenel M, Av\u015far E, Imery\u00fcz N, et al. Effects of selective COX-2 inhibitors on the gastric permeability of sucrose: a controlled study with placebo and ibuprofen. Eur J Gastroenterol Hepatol. 2003;15(4):403\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"2377_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1368-5031.2004.00155.x","volume":"58","author":"D Kellstein","year":"2004","unstructured":"Kellstein D, Ott D, Jayawardene S, Fricke J. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain. Int J Clin Pract. 2004;58(3):244\u201350.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2377_CR27","first-page":"534","volume":"47","author":"A Nadarajah","year":"2006","unstructured":"Nadarajah A, Abrahan L, Lau FL, Hwang LJ, Fakir-Bolte C. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Singapore Med J. 2006;47(6):534\u201342.","journal-title":"Singapore Med J"},{"issue":"2","key":"2377_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/147323000203000212","volume":"30","author":"LL Weckx","year":"2002","unstructured":"Weckx LL, Ruiz JE, Duperly J, et al. Efficacy of celecoxib in treating symptoms of viral pharyngitis: a double-blind, randomized study of celecoxib versus diclofenac. J Int Med Res. 2002;30(2):185\u201394.","journal-title":"J Int Med Res"},{"issue":"9","key":"2377_CR29","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s00464-004-8254-x","volume":"19","author":"Z Alanoglu","year":"2005","unstructured":"Alanoglu Z, Ates Y, Orbey BC, Turkcapar AG. Preoperative use of selective COX-II inhibitors for pain management in laparoscopic nissen fundoplication. Surg Endosc. 2005;19(9):1182\u20137.","journal-title":"Surg Endosc"},{"issue":"10","key":"2377_CR30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/pm\/pnw012","volume":"17","author":"C Argoff","year":"2016","unstructured":"Argoff C, McCarberg B, Gudin J, Nalamachu S, Young C. SoluMatrix\u00ae diclofenac: sustained opioid-sparing effects in a phase 3 study in patients with postoperative pain. Pain Med. 2016;17(10):1933\u201341.","journal-title":"Pain Med"},{"issue":"1","key":"2377_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jpain.2007.08.004","volume":"9","author":"J Fricke","year":"2008","unstructured":"Fricke J, Davis N, Yu V, Krammer G. Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial. J Pain. 2008;9(1):20\u20137.","journal-title":"J Pain"},{"issue":"1","key":"2377_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/humrep\/dev291","volume":"31","author":"A Hassan","year":"2016","unstructured":"Hassan A, Wahba A, Haggag H. Tramadol versus celecoxib for reducing pain associated with outpatient hysteroscopy: a randomized double-blind placebo-controlled trial. Hum Reprod. 2016;31(1):60\u20136.","journal-title":"Hum Reprod"},{"issue":"9","key":"2377_CR33","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00192-020-04411-4","volume":"32","author":"D Latif","year":"2021","unstructured":"Latif D, Darweesh FF, Osman OM, Abdelhakim AM, Nabil H, Ashour ASA. Oral tramadol versus oral celecoxib for analgesia after mediolateral episiotomy repair in obese primigravidae: a randomized controlled trial. Int Urogynecol J. 2021;32(9):2465\u201372.","journal-title":"Int Urogynecol J"},{"issue":"11","key":"2377_CR34","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1007\/s00402-023-04943-6","volume":"143","author":"Y Li","year":"2023","unstructured":"Li Y, An M, Ding Y, Wang C, Qiu Y. Oxycodone-acetaminophen versus celecoxib for postoperative pain in knee osteoarthritis patients after total knee arthroplasty: a randomized, controlled study. Arch Orthop Trauma Surg. 2023;143(11):6753\u201362.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"2377_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1479-828X.2007.00808.x","volume":"48","author":"SS Lim","year":"2008","unstructured":"Lim SS, Tan PC, Sockalingam JK, Omar SZ. Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: a randomised trial. Aust N Z J Obstet Gynaecol. 2008;48(1):71\u20137.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"10","key":"2377_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0149-2918(99)80045-9","volume":"21","author":"K Malmstrom","year":"1999","unstructured":"Malmstrom K, Daniels S, Kotey P, Seidenberg BC, Desjardins PJ. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther. 1999;21(10):1653\u201363.","journal-title":"Clin Ther"},{"issue":"10","key":"2377_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0149-2918(02)80059-5","volume":"24","author":"K Malmstrom","year":"2002","unstructured":"Malmstrom K, Fricke JR, Kotey P, Kress B, Morrison B. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model. Clin Ther. 2002;24(10):1549\u201360.","journal-title":"Clin Ther"},{"issue":"3","key":"2377_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0149-2918(07)80078-6","volume":"29","author":"JB Moberly","year":"2007","unstructured":"Moberly JB, Xu J, Desjardins PJ, et al. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. Clin Ther. 2007;29(3):399\u2013412.","journal-title":"Clin Ther"},{"issue":"S1","key":"2377_CR39","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1017\/S0022215116009476","volume":"131","author":"TT Ng","year":"2017","unstructured":"Ng TT, Diamantaras D, Priestley J, Redman J, De Silva N, Mahanta V. Is celecoxib a useful adjunct in the treatment of post-tonsillectomy pain in the adult population? A randomised, double-blind, placebo-controlled study. J Laryngol Otol. 2017;131(S1):S18\u201328.","journal-title":"J Laryngol Otol"},{"issue":"6","key":"2377_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00266-005-0032-1","volume":"29","author":"AA Parsa","year":"2005","unstructured":"Parsa AA, Soon CW, Parsa FD. The use of celecoxib for reduction of pain after subpectoral breast augmentation. Aesthetic Plast Surg. 2005;29(6):441\u20134 (discussion 445).","journal-title":"Aesthetic Plast Surg"},{"issue":"1","key":"2377_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/j.pain.0000000000002312","volume":"163","author":"N Singla","year":"2022","unstructured":"Singla N, Bertoch T, Shenoy S, Munjal S. Efficacy and safety of single-dose DFN-15 for treatment of acute postsurgical dental pain: a randomized, double-blind, placebo-controlled study. Pain. 2022;163(1):91\u20139.","journal-title":"Pain"},{"issue":"12","key":"2377_CR42","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.9980","volume":"15","author":"Z Suhrabi","year":"2013","unstructured":"Suhrabi Z, Taghinejad H. A comparative study on the efficacy of Ibuprofen and celecoxib on the intensity of perineal pain following episiotomy: a randomized clinical trial. Iran Red Crescent Med J. 2013;15(12):e9980.","journal-title":"Iran Red Crescent Med J"},{"issue":"20","key":"2377_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006844","volume":"96","author":"J Tang","year":"2017","unstructured":"Tang J, Fan J, Yao Y, Cai W, Yin G, Zhou W. Application of a buprenorphine transdermal patch for the perioperative analgesia in patients who underwent simple lumbar discectomy. Medicine (Baltimore). 2017;96(20):e6844.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2377_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00404-018-4653-4","volume":"297","author":"H Tintara","year":"2018","unstructured":"Tintara H, Voradithi P, Choobun T. Effectiveness of celecoxib for pain relief and antipyresis in second trimester medical abortions with misoprostol: a randomized controlled trial. Arch Gynecol Obstet. 2018;297(3):709\u201315.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"2377_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1213\/01.ANE.0000053255.93270.31","volume":"96","author":"MF Watcha","year":"2003","unstructured":"Watcha MF, Issioui T, Klein KW, White PF. Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery. Anesth Analg. 2003;96(4):987\u201394.","journal-title":"Anesth Analg"},{"issue":"5","key":"2377_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/BF03022655","volume":"54","author":"PF White","year":"2007","unstructured":"White PF, Sacan O, Tufanogullari B, Eng M, Nuangchamnong N, Ogunnaike B. Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth. 2007;54(5):342\u20138.","journal-title":"Can J Anaesth"},{"issue":"2","key":"2377_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1213\/ANE.0b013e3182025a8a","volume":"112","author":"PF White","year":"2011","unstructured":"White PF, Tang J, Wender RH, et al. The effects of oral ibuprofen and celecoxib in preventing pain, improving recovery outcomes and patient satisfaction after ambulatory surgery. Anesth Analg. 2011;112(2):323\u20139.","journal-title":"Anesth Analg"},{"issue":"2","key":"2377_CR48","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/ar1854","volume":"8","author":"RH Wittenberg","year":"2006","unstructured":"Wittenberg RH, Schell E, Krehan G, et al. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]. Arthritis Res Ther. 2006;8(2):R35.","journal-title":"Arthritis Res Ther"},{"key":"2377_CR49","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2147\/JPR.S153456","volume":"11","author":"C Xu","year":"2018","unstructured":"Xu C, Li M, Wang C, Li H, Liu H. Perioperative analgesia with a buprenorphine transdermal patch for hallux valgus surgery: a prospective, randomized, controlled study. J Pain Res. 2018;11:867\u201373.","journal-title":"J Pain Res"},{"issue":"4","key":"2377_CR50","first-page":"431","volume":"11","author":"B Zamiri","year":"2009","unstructured":"Zamiri B, Mousavizadeh K, Tajoddini M, Mohammadinezhad C, Aarabi A. Comparison of ibuprofen, celecoxib and tramadol in relief of pain after extraction of mandibular third molar teeth. Iran Red Crescent Med J (IRCMJ). 2009;11(4):431\u20136.","journal-title":"Iran Red Crescent Med J (IRCMJ)"},{"issue":"4","key":"2377_CR51","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s10787-023-01260-7","volume":"31","author":"K Zhang","year":"2023","unstructured":"Zhang K, Miao X, Jiang L, Cui S, Liu Z, Wang Z. Postoperative analgesic efficacy and safety of imrecoxib versus celecoxib in hip osteoarthritis patients undergoing total hip arthroplasty: a multi-center, randomized, controlled, non-inferiority study. Inflammopharmacology. 2023;31(4):1813\u201322.","journal-title":"Inflammopharmacology"},{"key":"2377_CR52","unstructured":"Schug SA, P.G., Scott DA, Alcock M, Halliwell R, Mott JF, . Acute Pain Management Scientific Evidence 5th edition. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. 2020; https:\/\/www.anzca.edu.au\/safety-and-advocacy\/advocacy\/college-publications\/acute-pain-management-scientific-evidence."},{"key":"2377_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1909","volume":"357","author":"M Bally","year":"2017","unstructured":"Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909.","journal-title":"BMJ"},{"key":"2377_CR54","unstructured":"Australian Medicines Handbook [Internet]. Adelaide: AMH Pty Ltd; [cited 2025 Dec 15]. https:\/\/amhonline.amh.net.au\/."},{"key":"2377_CR55","unstructured":"Therapeutic Guidelines. Rheumatology. Melbourne: Therapeutic Guidelines Limited; accessed December 15, 2025. https:\/\/www.tg.org.au. 2024."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02377-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02377-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02377-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:04:52Z","timestamp":1790366692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-026-02377-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02377-z","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CMC acted as a paid consultant to Viatris Pty Ltd. DP is an employee of Viatris and provided no input on the interpretation of study findings or conduct of the analysis. Authors YT, JH, PB, MH, and PF declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate and Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data that support the findings of this study are available on request from the corresponding author.","order":4,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The lead author affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as originally planned have been explained.","order":6,"name":"Ethics","label":"Transparency","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Carlos Mesa-Castrillon: conceptualisation, methodology, formal analysis, writing \u2013 original draft, writing \u2013 review & editing, project administration. Ye Tian: conceptualisation, methodology, formal analysis, writing \u2013 review & editing. Jessica Hughes: methodology, formal analysis, writing \u2013 review & editing. Paula Beckenkamp: conceptualisation, methodology, formal analysis, writing \u2013 review & editing. Michelle Hall: conceptualisation, methodology, formal analysis, writing \u2013 review & editing. Dimitri Papadimitriou: Conceptualisation, methodology and review. Paulo Ferreira: conceptualisation, methodology, formal analysis, writing \u2013 original draft, writing \u2013 review & editing. All authors have read and approved the final version","order":7,"name":"Ethics","label":"Authors\u2019\u00a0Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}